This application is a U.S. national stage application of International Patent Application No. PCT/EP2017/077154, filed on Oct. 24, 2017, which claims priority to GB Application No. 1618298.2, filed Oct. 28, 2016, entitled MULTI-LAYERED WOUND DRESSING AND METHOD OF MANUFACTURE.
The present invention relates to a multi-layered wound dressing and a method of manufacturing such a wound dressing. In particular, but not exclusively, embodiments of the present invention relate to a multi-layered wound dressing having a fibrous absorbent layer that can resist shrinkage even under extreme sterilisation methods and storage conditions, have improved aesthetics and mechanical strength and thereby increase consistency of product over its shelf life.
Wound dressings can be formed with a liquid-impermeable top layer (outer layer, furthest from the wound), which prevents wound exudates striking through and leaking from the dressing. The top layer is often also gas permeable and liquid vapour permeable, to help minimise maceration to the wound.
In some known wound dressings, the liquid-impermeable top layer can be susceptible to wrinkling (wrinkling includes but is not limited to inconsistent appearance, crinkles, creases textured surface). Wrinkling may occur whilst the wound dressing is packaged in a sterile packaging, and may be due to shrinking of one or more wound dressing layers over time. This may be due to the type of packaging and sterilisation method chosen. It could be perceived by a medical practitioner that if wrinkling is present the product has been compromised. Thus, it may not be possible to determine whether the wound dressing is still suitable for use. Wrinkling of the top layer may also occur whilst the wound dressing is in use. A wrinkled wound dressing is also visually unappealing to a patient.
Wound dressings often require a product shelf life of as long as possible, typically 5 years, so it is desirable to produce a wound dressing in which the liquid impermeable top layer is not as likely to wrinkle, become inconsistent in appearance or change aesthetics over time.
EP 1,314,410 discloses a multi-layered wound dressing having top film layer, but does not disclose any way of reducing or preventing shrinkage or wrinkling of the dressing.
According to a first aspect of the present invention there is provided a multi-layered wound dressing comprising:
According to a second aspect of the present invention there is provided a method of manufacturing a multi-layered wound dressing, the method comprising:
According to a third aspect of the present invention there is provided a method of treating a wound comprising placing a multi-layered wound dressing according to any embodiment disclosed herein over a wound.
According to a fourth aspect of the present invention there is provided a method of providing negative pressure wound therapy to a wound, the method comprising:
According to a fifth aspect of the present invention there is provided a method of operating a negative pressure wound system, the method comprising:
According to a sixth aspect of the present invention there is provided a negative pressure wound therapy kit comprising a multi-layered wound dressing according to any embodiment disclosed herein and a negative pressure source configured to be fluidically connected to the wound dressing.
According to another aspect there is provided a multi-layered wound dressing comprising:
According to another aspect there is provided a multi-layered wound dressing comprising:
According to another aspect there is provided a multi-layered wound dressing comprising:
According to another aspect there is provided a multi-layered wound dressing comprising:
Certain embodiments of the invention provide the advantage that at least part of the wound dressing is less likely to shrink over time compared to known wound dressings.
Certain aspects of the invention provide a wound dressing in which wrinkling in a layer or layers of a wound dressing, e.g. a liquid impermeable film layer is prevented or reduced.
Embodiments of the invention are further described hereinafter with reference to the accompanying drawings, in which:
In the drawings like reference numerals refer to like parts.
The film layer 102 is also gas and vapour permeable to allow for evaporation of fluid or wound exudate from the wound dressing 100, and help prevent maceration of the wound. In this example, the film layer 102 is formed from a polyurethane blend, though other suitable materials may include other polymeric materials, for example polyethylene, or polypropylene.
An absorbent layer 108 underlies the film layer 102. The absorbent layer 108 has a fibrous structure for absorbing exudate from a wound site. In this example, the absorbent layer 108 includes superabsorbent fibres. The absorbent layer 108 also includes other fibres. In this example, the absorbent layer includes superabsorbent fibres, viscose fibres and polyester fibres.
In this example, the absorbent layer 108 includes around 40% superabsorbent fibres, 40% viscose fibres, and 20% polyester fibres. In other examples, the absorbent layer may include around 0-50% superabsorbent fibres, 0-100% viscose fibres and 0-50% polyester fibres. Suitable superabsorbent fibres include crosslinked acrylate copolymer fibres that are partially neutralized to sodium salt however other superabsorbent fibres are available. The absorbent layer 108 may be manufactured using a needling process in which the fibres are mechanically tangled together.
In other examples, the absorbent layer may include other ratios of superabsorbent, viscose and polyester fibres. For example, the absorbent layer may include around 50% superabsorbent fibres, 35% viscose fibres and 20% polyester fibres. Alternatively, the absorbent layer may include 40% superabsorbent fibres and 60% viscose fibres.
The film layer 102 is located over the absorbent layer 108 so that wound exudate collected in the absorbent layer 108 can evaporate out of the wound dressing 100 through the film layer 102.
A support layer 106 is located between the film layer 102 and the absorbent layer 108. The support layer 106 helps to reinforce the structure of the absorbent layer 108 and thereby reduce shrinkage of the wound dressing 100. The support layer 102 also helps to provide extra mechanical strength to the film layer 102 to reduce or prevent wrinkling of the film layer 102 over time. The mechanical strength also reduces the chance of the dressing deforming or rolling up causing a pressure point.
Aptly, the support layer 106 is configured to have a tensile strength from 0.05 to 0.06 Nm to provide mechanical strength to the surrounding layers (e.g. the film layer 102 and the absorbent layer 108) without compromising the flexibility of the wound dressing 100. The support layer 106 may have a thickness of from 50 to 150 μm. Aptly, the support layer 106 may have a thickness of around 100 to 110 μm.
Referring to
In this example, the net 200 has a substantially hexagonal (or honeycomb) structure 204 including a plurality of substantially triangular shaped apertures 202 extending therethrough.
The hexagonal structure 204 is formed from a plurality of dots (or bosses) 206 joined by polymer strands 208. The dots 206 are substantially evenly spaced with respect to each other. Each dot forms a vertex of the hexagonal pattern in the structure 204. Each dot 206 is joined to six surrounding dots 206 by polymer strands 208. That is, six polymer strands 208 extend from each dot 206 and each connect to a respective surrounding dot 206 to form the hexagonal structure 204 having triangular shaped apertures 202 between the polymer strands 208.
Each of the triangular shaped apertures 202 may have an area A of from 0.005 to 0.32 mm2. This allows liquid vapour from a wound to pass freely through the apertures, whilst still providing sufficient strength to the support layer 106.
It can also be said that the structure 204 is a structure comprising a plurality of strands or struts that are joined to form a plurality of triangles. In this example the triangles tessellate in rows. It will be appreciated that the strands or struts may be arranged in other formations, for example squares, diamonds or rectangles with different geometries and therefore differing open areas.
In this example, the support layer 106 is located directly adjacent the absorbent layer 108. As such, the support layer 106 can effectively provide additional mechanical strength to fibres in the top surface of the absorbent layer 108. This can help prevent movement of the fibres and reduce shrinking of the absorbent layer 108.
Aptly, the support layer 106 is bonded to the fibres in the top surface of the absorbent layer 108. This can help to lock the fibres in position and prevent or reduce any movement. In this example, the support layer 106 further includes a bonding layer for heat laminating the net 200 to the absorbent layer 108. The support layer 106 is thus heat laminated to fibres in the absorbent layer 108 via the bonding layer.
The bonding layer contained within the net has a lower melting temperature than the net 200 so that the support layer 106 can be heat laminated to the absorbent layer 108 whilst maintaining the structure of the net 200. The bonding layer can be formed from a low melting point polymer, for example a low melting point ethylene-vinyl acetate, whilst the net 200 may be formed from a high density polyethylene, which melts at a higher temperature than the bonding layer. Other polymers having a lower melting point than the net 200 may also be suitable. For example the bonding layer may be a separate layer or alternatively include an ethylene-acrylate or thermoplastic polyurethane based adhesive.
The net 200 and the bonding layer can be coextruded to form the support layer 106. Aptly, the bonding layer is extruded with a similar structural shape to the net 200, so that the apertures 202 in the net 200 are not obstructed by the bonding layer. This helps to ensure that exudate the absorbent layer 108 can pass through the support layer and evaporate out of the wound dressing 100 through the film layer 102.
The wound dressing 300 also includes a first adhesive layer 304, located between the film layer 302 and the support layer 306, for attaching the film layer 302 to the support layer 306. The first adhesive layer 304 is a hot melt adhesive applied to a wound facing side (underside) of the film layer 302. Aptly, the first adhesive layer 304 is pattern coated onto the film layer 302, to include holes, so that gas and liquid vapour can pass through holes in the first adhesive layer 304. In other examples the film layer 302 may be laminated (e.g. heat laminated) directly onto the support layer 306 without the need for an adhesive layer 304 in between.
In this example, the wound dressing 300 also includes a foam layer 312, which is a fluid transport layer. The foam layer 312 is located under the absorbent layer 306. The foam layer 312 acts to draw fluid away from a wound site and transport the fluid to the absorbent layer 308. The foam layer may be formed from an open cell polyurethane foam and other options are available, as will be recognised by those skilled in the art.
An adhesive web layer 310 is located between the foam layer 312 and the absorbent layer 308 to adhere the foam layer 312 to the absorbent layer 308. The adhesive web layer may be formed from bicomponent polypropylene/polyethylene fibres. Such bicomponent fibres are known in the art, so for brevity will not be discussed in detail. The adhesive web layer 310 includes a plurality of apertures extending therethrough to allow for passage of exudate from the foam layer 312 to the absorbent layer 108.
The wound dressing 300 also includes a wound contact layer 320, which includes a perforated film 316. The perforated film 316 is located under the foam layer 312 and helps to prevent the wound dressing 300 from attaching to the wound as the wound heals. For example, where the wound dressing 300 includes the foam layer 312, the perforated film 316 can prevent new tissue from growing into cells of the foam layer 312. In other examples, the foam layer 312 may not be present and the perforated film 316 can help prevent fibres of the absorbent layer 308 from becoming embedded in the wound. Perforations in the perforated film 316 are aptly substantially uniformly distributed and are of suitable size to allow passage of exudate into the wound dressing 300, e.g. with holes having a diameter of 1-2.5 mm. The perforated film 316 is aptly formed from polyurethane.
The wound contact layer 320 may also include an adhesive 318 located under the perforated film 316 (i.e. on the wound facing side of the perforated film 316) for adhering the wound dressing 300 to the skin. In this case the adhesive is silicone 318 and is aptly spread onto the underside of the perforated film with a coat weight of around 30-200 g/m2. In some other examples, an additional attachment element, for example bandages, strips of tape, or compression bandages may be used to secure the wound dressing 300 to the patient.
The top side of the perforated film 316 (i.e. the side distal from the wound) may be coated with a further adhesive layer 314. The further adhesive layer 314 adheres the wound contact layer 320 to the foam layer 312. Aptly, the further adhesive layer 314 may be an acrylic adhesive, though other suitable adhesives may also be used. In other examples the wound contact layer 320 may be laminated (e.g. heat laminated) directly to the foam layer 312, without the need for the further adhesive layer 314 in between.
The film layer 302 may be formed by extrusion. At step 401, the first adhesive layer 304 is applied to the film layer. Aptly, the first adhesive layer 304 is pattern coated onto the underside of the extruded film layer 302.
At step 402 the support layer 306 and the absorbent layer 308 are heat laminated together to form a single piece. At step 403 the film layer 302 and first adhesive layer 304 are heat laminated to the support layer 306 on the top side of the single piece and the adhesive web layer 310 and foam layer 312 are heat laminated to the absorbent layer 308. Whilst the layers have been described as being heat laminated together in a specific order, the layers may be separately laminated together or laminated together all at the same time.
At step 404 the wound contact layer 320 is formed by coating one side of a film layer with the silicone adhesive layer 314, and coating the other side of the film layer with a further adhesive layer 314. The film layer is then perforated at step 405 (e.g. by needle punching), to form the wound contact layer 320 including the perforated film 316, the silicone adhesive layer 314 for contacting the wound and the further adhesive layer 314. Alternatively, the film layer may be perforated before adding the further adhesive layer 314.
The wound contact layer may then be laminated (e.g. with heat, ultrasonic and/or radio frequency welding) to the underside of the foam layer 312 to form the wound dressing 300, as shown at step 406.
At step 407 a removable cover may be applied to the underside of the silicone adhesive layer 318. This cover can be removed before the wound dressing 300 is applied to a patient.
At step 408 the wound dressing 300 may be cut into separate wound dressing pieces, each suitably sized for an intended application.
In another example, as shown in
In this example, the wound dressing may be manufactured following steps 401 to 407 described above. However, instead of cutting the dressing to size (step 408) each wound dressing may be made individually with each layer cut or formed to the desired size prior to laminating all the layers together so that the final wound dressing has a film layer larger than the other layers.
In a further example, as shown in
The wound dressing 600 in this example may be manufactured similarly to the wound dressing 300, as described above, but with the film layer 602 and the wound contact layer 620 being laminated together around the periphery (e.g. via the adhesive layer 604) to sandwich the remaining layers between the film layer 602 and the wound contact layer 620. Alternatively, the film layer 602 may be directly laminated around the periphery (e.g. heat laminated) to the wound contact layer 620, without the need for the additional adhesive layer 604.
Although the wound dressings 300, 500, 600 have been described having several adhesive layers, one or more of these layers may not be present. For example, the perforated film itself may be formed from a hot melt adhesive material so that it can be directly heat laminated onto the foam layer, in which case the further adhesive layer may not be needed. In another example, the adhesive web layer may not be present if the foam and absorbent layers are adhered in another way. For example, the foam and absorbent layers may be directly chemically bonded together. Similarly, the first adhesive layer may not be needed. For example if the support layer includes an adhesive material, or if the film layer itself is formed from a hot melt adhesive then the film layer and the support layer may be directly adhered together.
In another example, the wound dressing may be provided without the foam layer. The foam layer helps to transport exudate away from the wound. However in some cases, and depending on the severity of a wound, the absorbent layer may sufficiently draw exudate from the wound without the need for the foam layer.
Although in the examples described above, the support layer is heat laminated to the absorbent layer via a bonding layer, other laminating techniques may be suitable. For example, the bonding layer may include a pressure sensitive adhesive. In this case, heat may not be required to laminate the support layer and adhesive layer together.
Although in the example described above, the net layer has been described as having a substantially hexagonal shaped structure, other geometric structures may also be suitable.
With other geometric structures, the apertures may also have different geometric shapes.
In another example, the wound dressing may include more than one support layer to provide support to other layers in the wound dressing. For example a first support layer may be located between the liquid impermeable film layer and the absorbent layer, and a further support layer may be located between the absorbent layer and the fluid transport layer (foam layer). This may help to support the absorbent layer from both sides to further reduce shrinking of the absorbent layer.
Any of the examples described herein may be adapted for use with a negative pressure system (sometimes referred to as a reduced pressure system) including a source of negative pressure, such as a negative pressure pump. For example, the film layer may include a negative pressure interface, such as a port, to which a negative pressure supply tube may be connected. The supply tube may be connected to a negative pressure source so that, in use, the negative pressure source applies a negative pressure to the wound dressing between the film layer and the wound to help draw wound exudate away from the wound and into the absorbent layer of the dressing.
The conduit 740 can be any suitable article configured to provide at least a substantially sealed fluid flow path or pathway between the negative pressure device 750 and the wound cavity 710 so as to supply reduced pressure to the wound cavity. The conduit 740 can be formed from polyurethane, PVC, nylon, polyethylene, silicone, or any other suitable rigid or flexible material. In some embodiments, the wound dressing 720 can have a port configured to receive an end of the conduit 740. For example, a port can include a hole in the film layer. In some embodiments, the conduit 740 can otherwise pass through and/or under a film layer of the wound dressing 720 to supply reduced pressure to the wound cavity 710 so as to maintain a desired level of reduced pressure in the wound cavity. In some embodiments, at least a part of the conduit 740 is integral with or attached to the wound dressing 720.
In use, the wound dressing, such as the wound dressing 100, 300, 500, or 600, is applied to a wound site with the wound contact layer 320 contacting the wound. Exudate from the wound may pass through the perforated film 116 and into the foam layer 312, which acts to transport wound exudate away from the wound into the absorbent layer 308. Wound exudate collected in the absorbent layer 308 can evaporate from the wound dressing 300 through the vapour permeable film layer 302.
The support layer helps to provide mechanical strength to the absorbent layer, which may swell when it is wet and may shrink as it dries. The support layer can help to minimise movement of fibres in the absorbent layer at least on the side distal from the wound and thus helps to prevent shrinking of the wound dressing, particularly in this region. Minimising shrinking of the wound dressing in this way can in turn can help to prevent wrinkling of the film layer. It also reduced the chance of the dressing rolling/folding up under secondary retention.
As the wound dressing becomes exposed to moisture (either from the wound or the surrounding atmosphere), it may swell or expand causing increased wrinkling of the film layer. Having the support layer adhered to the film layer can help to provide support to the film layer and resist wrinkling of the film layer by providing additional mechanical strength to the film layer.
The above described wound dressings are less likely to exhibit shrinking whilst stored in sterile packaging than previously known wound dressings. Thus, wrinkling of the film layer on the outside of the wound dressing can be prevented or reduced. A medical practitioner is therefore less likely to disregard a wound dressing that is still within its recommended shelf life, sterile and suitable for use, purely because of visual appearance of the film layer.
The hexagonal and/or triangular shape of the net structure of the support layer helps to provide mechanical strength and can be particularly effective at resisting against shrinkage of surrounding wound dressing layers.
Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of them mean “including but not limited to”, and they are not intended to (and do not) exclude other moieties, additives, components, integers or steps. Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The invention is not restricted to the details of any foregoing embodiments. The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
The reader's attention is directed to all papers and documents which are filed concurrently with or previous to this specification in connection with this application and which are open to public inspection with this specification, and the contents of all such papers and documents are incorporated herein by reference.
Number | Date | Country | Kind |
---|---|---|---|
1618298 | Oct 2016 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2017/077154 | 10/24/2017 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2018/077872 | 5/3/2018 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
730062 | Widmer | Jun 1903 | A |
1052274 | Purdy | Feb 1913 | A |
2054768 | Gale, Jr. et al. | Sep 1936 | A |
2233209 | Herzog | Feb 1941 | A |
2280506 | Betts | Apr 1942 | A |
2682873 | Idnis et al. | Jul 1954 | A |
2905174 | Smith | Sep 1959 | A |
2992644 | Plantinga et al. | Jul 1961 | A |
3043301 | Plantinga et al. | Jul 1962 | A |
3156242 | Crowe, Jr. et al. | Nov 1964 | A |
3204277 | Sierik et al. | Sep 1965 | A |
3301429 | McClain | Jan 1967 | A |
3416524 | Meier | Dec 1968 | A |
3529597 | Fuzak et al. | Sep 1970 | A |
3616154 | Dow et al. | Oct 1971 | A |
3687136 | Carmody | Aug 1972 | A |
4212296 | Schaar | Jul 1980 | A |
4649909 | Thompson | Mar 1987 | A |
4798603 | Meyer et al. | Jan 1989 | A |
4834735 | Alemany et al. | May 1989 | A |
4846164 | Martz | Jul 1989 | A |
4901714 | Jensen | Feb 1990 | A |
4968181 | Goldman | Nov 1990 | A |
4973325 | Sherrod et al. | Nov 1990 | A |
4988344 | Reising et al. | Jan 1991 | A |
4988345 | Reising | Jan 1991 | A |
5018515 | Gilman | May 1991 | A |
5021050 | Iskra | Jun 1991 | A |
5037409 | Chen et al. | Aug 1991 | A |
5065600 | Byles | Nov 1991 | A |
5115801 | Cartmell et al. | May 1992 | A |
5124197 | Bernardin et al. | Jun 1992 | A |
5149334 | Lahrman et al. | Sep 1992 | A |
5151091 | Glaug et al. | Sep 1992 | A |
5160328 | Cartmell et al. | Nov 1992 | A |
5171391 | Chmielewski et al. | Dec 1992 | A |
5175046 | Nguyen | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5197945 | Cole et al. | Mar 1993 | A |
5217445 | Young et al. | Jun 1993 | A |
5236427 | Hamajima et al. | Aug 1993 | A |
5242435 | Murji et al. | Sep 1993 | A |
5257982 | Cohen et al. | Nov 1993 | A |
5271987 | Iskra | Dec 1993 | A |
5281208 | Thompson et al. | Jan 1994 | A |
5294478 | Wanek et al. | Mar 1994 | A |
5296290 | Brassington | Mar 1994 | A |
5314743 | Meirowitz et al. | May 1994 | A |
5318554 | Young et al. | Jun 1994 | A |
5330456 | Robinson | Jul 1994 | A |
5336219 | Krantz | Aug 1994 | A |
5342336 | Meirowitz et al. | Aug 1994 | A |
5348547 | Payne et al. | Sep 1994 | A |
5354261 | Clark et al. | Oct 1994 | A |
5356405 | Thompson et al. | Oct 1994 | A |
5360420 | Cook et al. | Nov 1994 | A |
5364381 | Soga et al. | Nov 1994 | A |
5364382 | Latimer et al. | Nov 1994 | A |
5366451 | Levesque | Nov 1994 | A |
5368909 | Langdon et al. | Nov 1994 | A |
5368926 | Thompson et al. | Nov 1994 | A |
5374260 | Lemay et al. | Dec 1994 | A |
5380294 | Persson | Jan 1995 | A |
5382245 | Thompson et al. | Jan 1995 | A |
5387208 | Ashton et al. | Feb 1995 | A |
5387209 | Yamamoto et al. | Feb 1995 | A |
5397316 | LaVon et al. | Mar 1995 | A |
5401267 | Couture-Dorschner et al. | Mar 1995 | A |
5425725 | Tanzer et al. | Jun 1995 | A |
5431643 | Ouellette et al. | Jul 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5447492 | Cartmell et al. | Sep 1995 | A |
5454800 | Hirt et al. | Oct 1995 | A |
5456660 | Reich et al. | Oct 1995 | A |
5465735 | Patel | Nov 1995 | A |
5470326 | Dabi et al. | Nov 1995 | A |
H1511 | Chappell et al. | Dec 1995 | H |
5480377 | Cartmell et al. | Jan 1996 | A |
5486167 | Dragoo et al. | Jan 1996 | A |
5487736 | Van Phan | Jan 1996 | A |
5497788 | Inman et al. | Mar 1996 | A |
5500270 | Langdon et al. | Mar 1996 | A |
5505719 | Cohen et al. | Apr 1996 | A |
5509914 | Osborn, III | Apr 1996 | A |
5514120 | Johnston et al. | May 1996 | A |
5520629 | Heinecke et al. | May 1996 | A |
5525407 | Yang | Jun 1996 | A |
5536264 | Hsueh et al. | Jul 1996 | A |
5538500 | Peterson | Jul 1996 | A |
H1585 | Ahr | Aug 1996 | H |
5545155 | Hseih et al. | Aug 1996 | A |
5549584 | Gross | Aug 1996 | A |
5549589 | Horney et al. | Aug 1996 | A |
5562107 | Lavender et al. | Oct 1996 | A |
5562646 | Goldman et al. | Oct 1996 | A |
5562650 | Everett et al. | Oct 1996 | A |
5579765 | Cox et al. | Dec 1996 | A |
5591148 | McFall et al. | Jan 1997 | A |
5591149 | Cree et al. | Jan 1997 | A |
5593395 | Martz | Jan 1997 | A |
5603707 | Trombetta et al. | Feb 1997 | A |
5603946 | Constantine | Feb 1997 | A |
5609588 | DiPalma et al. | Mar 1997 | A |
5613960 | Mizutani | Mar 1997 | A |
5614283 | Potnis et al. | Mar 1997 | A |
5614295 | Quincy, III et al. | Mar 1997 | A |
5628736 | Thompson | May 1997 | A |
5632731 | Patel | May 1997 | A |
H1657 | Hammons et al. | Jun 1997 | H |
5634915 | Osterdahl | Jun 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5637080 | Geng | Jun 1997 | A |
5643238 | Baker | Jul 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5648142 | Phillips | Jul 1997 | A |
5649915 | Chauvette et al. | Jul 1997 | A |
5649916 | DiPalma et al. | Jul 1997 | A |
5662599 | Reich et al. | Sep 1997 | A |
5665082 | Boulanger | Sep 1997 | A |
5669895 | Murakami et al. | Sep 1997 | A |
5675079 | Gilman et al. | Oct 1997 | A |
5683354 | Levy | Nov 1997 | A |
5700254 | McDowall et al. | Dec 1997 | A |
5702356 | Hathman | Dec 1997 | A |
5704905 | Jensen et al. | Jan 1998 | A |
5713384 | Roach et al. | Feb 1998 | A |
5713842 | Kay | Feb 1998 | A |
5716703 | Payne | Feb 1998 | A |
5728084 | Palumbo et al. | Mar 1998 | A |
5728085 | Widlund et al. | Mar 1998 | A |
5733273 | Ahr | Mar 1998 | A |
5752945 | Mosley et al. | May 1998 | A |
5762641 | Bewick-Sonntag et al. | Jun 1998 | A |
5788684 | Abuto et al. | Aug 1998 | A |
5801107 | Everhart et al. | Sep 1998 | A |
5810798 | Finch et al. | Sep 1998 | A |
5817081 | LaVon et al. | Oct 1998 | A |
5820578 | Johansen | Oct 1998 | A |
5827213 | Jensen | Oct 1998 | A |
5827254 | Trombetta et al. | Oct 1998 | A |
5830202 | Bogdanski et al. | Nov 1998 | A |
5837627 | Halabisky et al. | Nov 1998 | A |
5840052 | Johns | Nov 1998 | A |
5843025 | Shaari | Dec 1998 | A |
5843064 | Koczab | Dec 1998 | A |
5855572 | Schmidt | Jan 1999 | A |
5865822 | Hamajima et al. | Feb 1999 | A |
5865824 | Chen et al. | Feb 1999 | A |
5873867 | Coles et al. | Feb 1999 | A |
5877097 | West et al. | Mar 1999 | A |
5891120 | Chmielewski | Apr 1999 | A |
5895379 | Litchholt et al. | Apr 1999 | A |
5897541 | Uitenbroek et al. | Apr 1999 | A |
5916507 | Dabi et al. | Jun 1999 | A |
5925026 | Arteman et al. | Jul 1999 | A |
5931823 | Stokes et al. | Aug 1999 | A |
5938995 | Koltisko, Jr. et al. | Aug 1999 | A |
5941863 | Guidotti et al. | Aug 1999 | A |
5947945 | Cree et al. | Sep 1999 | A |
5951535 | Fujiwara et al. | Sep 1999 | A |
5961506 | Guidotti et al. | Oct 1999 | A |
5968027 | Cole et al. | Oct 1999 | A |
5989478 | Ouellette et al. | Nov 1999 | A |
6022610 | Phan et al. | Feb 2000 | A |
6037518 | Guidotti et al. | Mar 2000 | A |
6040493 | Cooke et al. | Mar 2000 | A |
6060638 | Paul et al. | May 2000 | A |
6068620 | Chmielewski | May 2000 | A |
6071267 | Zamierowski | Jun 2000 | A |
6075177 | Bahia et al. | Jun 2000 | A |
6077526 | Scully et al. | Jun 2000 | A |
6096015 | Yeo et al. | Aug 2000 | A |
6103953 | Cree et al. | Aug 2000 | A |
6103954 | Grondin et al. | Aug 2000 | A |
6107539 | Palumbo et al. | Aug 2000 | A |
6124520 | Roberts | Sep 2000 | A |
6124521 | Roberts | Sep 2000 | A |
6127595 | Makoui et al. | Oct 2000 | A |
6142982 | Hunt et al. | Nov 2000 | A |
6168849 | Braverman et al. | Jan 2001 | B1 |
6191340 | Carlucci et al. | Feb 2001 | B1 |
6206865 | Chen et al. | Mar 2001 | B1 |
6223383 | Vanputten | May 2001 | B1 |
6235966 | Magnusson et al. | May 2001 | B1 |
6264776 | DiPalma | Jul 2001 | B1 |
6294710 | Schmidt et al. | Sep 2001 | B1 |
6297423 | Schoenfeldt et al. | Oct 2001 | B1 |
6344036 | Ivansson | Feb 2002 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6362390 | Carlucci et al. | Mar 2002 | B1 |
6369292 | Strack et al. | Apr 2002 | B1 |
6372952 | Lash et al. | Apr 2002 | B1 |
6403857 | Gross et al. | Jun 2002 | B1 |
6468295 | Augustine et al. | Oct 2002 | B2 |
6497689 | Schmidt et al. | Dec 2002 | B1 |
6506175 | Goldstein | Jan 2003 | B1 |
6506960 | Young et al. | Jan 2003 | B1 |
6521813 | Chihani | Feb 2003 | B1 |
6528696 | Ireland | Mar 2003 | B1 |
6534149 | Daley et al. | Mar 2003 | B1 |
6545194 | Schmidt et al. | Apr 2003 | B1 |
6551295 | Schmidt et al. | Apr 2003 | B1 |
6570057 | Schmidt et al. | May 2003 | B1 |
6570058 | Fuchs et al. | May 2003 | B1 |
6573424 | Raidel et al. | Jun 2003 | B1 |
6586653 | Graeme, III et al. | Jul 2003 | B2 |
6610898 | Magnusson et al. | Aug 2003 | B1 |
6610903 | Latimer et al. | Aug 2003 | B1 |
6613028 | Daley et al. | Sep 2003 | B1 |
6613953 | Altura | Sep 2003 | B1 |
6613955 | Lindsay et al. | Sep 2003 | B1 |
6626891 | Ohmstede | Sep 2003 | B2 |
6630611 | Malowaniec | Oct 2003 | B1 |
6648862 | Watson | Nov 2003 | B2 |
6664439 | Arndt et al. | Dec 2003 | B1 |
6683229 | Ehrnsperger et al. | Jan 2004 | B1 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6706940 | Worthley | Mar 2004 | B2 |
6719742 | McCormack et al. | Apr 2004 | B1 |
6727403 | Ehrnsperger et al. | Apr 2004 | B1 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6762337 | Boukanov et al. | Jul 2004 | B2 |
6764459 | Donaldson | Jul 2004 | B1 |
6776769 | Smith | Aug 2004 | B2 |
6783837 | Creagan et al. | Aug 2004 | B1 |
6787682 | Gilman | Sep 2004 | B2 |
6835192 | Guidotti et al. | Dec 2004 | B1 |
6838589 | Liedtke et al. | Jan 2005 | B2 |
6841715 | Roberts | Jan 2005 | B2 |
6878647 | Rezai | Apr 2005 | B1 |
6936037 | Bubb et al. | Aug 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6960181 | Stevens | Nov 2005 | B2 |
6998511 | Worthley | Feb 2006 | B2 |
7004915 | Boynton et al. | Feb 2006 | B2 |
7049478 | Smith | May 2006 | B1 |
7108683 | Zamierowski | Sep 2006 | B2 |
7112712 | Ancell | Sep 2006 | B1 |
7118545 | Boyde | Oct 2006 | B2 |
7122023 | Hinoki | Oct 2006 | B1 |
7122712 | Lutri et al. | Oct 2006 | B2 |
7183345 | Kim | Feb 2007 | B2 |
7195624 | Lockwood et al. | Mar 2007 | B2 |
7294751 | Propp et al. | Nov 2007 | B2 |
7294752 | Propp | Nov 2007 | B1 |
7381859 | Hunt et al. | Jun 2008 | B2 |
7429689 | Chen et al. | Sep 2008 | B2 |
7438705 | Karpowicz et al. | Oct 2008 | B2 |
7476205 | Erdmann | Jan 2009 | B2 |
7507870 | Nielsen et al. | Mar 2009 | B2 |
7511187 | Kelly | Mar 2009 | B2 |
7563940 | Kurata | Jul 2009 | B2 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
7576256 | Bjornberg et al. | Aug 2009 | B2 |
7605298 | Bechert et al. | Oct 2009 | B2 |
7615036 | Joshi et al. | Nov 2009 | B2 |
7622629 | Aali | Nov 2009 | B2 |
7645269 | Zamierowski | Jan 2010 | B2 |
7676257 | Suryanarayanan et al. | Mar 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7722582 | Lina et al. | May 2010 | B2 |
7723561 | Propp | May 2010 | B2 |
7749531 | Booher | Jul 2010 | B2 |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7775998 | Riesinger | Aug 2010 | B2 |
7776028 | Miller et al. | Aug 2010 | B2 |
7779625 | Joshi et al. | Aug 2010 | B2 |
7794438 | Henley et al. | Sep 2010 | B2 |
7838719 | Hilton, Jr. | Nov 2010 | B2 |
7838723 | Schmidt et al. | Nov 2010 | B1 |
7909805 | Weston | Mar 2011 | B2 |
7922703 | Riesinger | Apr 2011 | B2 |
7935066 | Shives et al. | May 2011 | B2 |
7959624 | Riesinger | Jun 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
7988673 | Wright et al. | Aug 2011 | B2 |
8021347 | Vitaris et al. | Sep 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8092436 | Christensen | Jan 2012 | B2 |
8147468 | Barta et al. | Apr 2012 | B2 |
8152785 | Vitaris | Apr 2012 | B2 |
8162907 | Heagle | Apr 2012 | B2 |
8168848 | Lockwood et al. | May 2012 | B2 |
8188331 | Barta et al. | May 2012 | B2 |
8202261 | Kazala, Jr. et al. | Jun 2012 | B2 |
8212101 | Propp | Jul 2012 | B2 |
8241261 | Randolph et al. | Aug 2012 | B2 |
8246606 | Stevenson et al. | Aug 2012 | B2 |
8252971 | Aali et al. | Aug 2012 | B2 |
8314283 | Kingsford et al. | Nov 2012 | B2 |
8328858 | Barsky et al. | Dec 2012 | B2 |
8372050 | Jaeb et al. | Feb 2013 | B2 |
8376972 | Fleischmann | Feb 2013 | B2 |
8382731 | Johannison | Feb 2013 | B2 |
8403899 | Sherman | Mar 2013 | B2 |
8404921 | Lee et al. | Mar 2013 | B2 |
8425478 | Olson | Apr 2013 | B2 |
8444611 | Wilkes et al. | May 2013 | B2 |
8449508 | Coulthard et al. | May 2013 | B2 |
8481804 | Timothy | Jul 2013 | B2 |
8513481 | Gergely et al. | Aug 2013 | B2 |
8535296 | Blott et al. | Sep 2013 | B2 |
8545466 | Andresen et al. | Oct 2013 | B2 |
8663198 | Buan et al. | Mar 2014 | B2 |
8680360 | Greener et al. | Mar 2014 | B2 |
8708998 | Weston et al. | Apr 2014 | B2 |
8715256 | Greener | May 2014 | B2 |
8722961 | Vinton et al. | May 2014 | B2 |
8764732 | Hartwell | Jul 2014 | B2 |
8791316 | Greener | Jul 2014 | B2 |
8795247 | Bennett et al. | Aug 2014 | B2 |
8801685 | Armstrong et al. | Aug 2014 | B2 |
8814842 | Coulthard et al. | Aug 2014 | B2 |
8843327 | Vernon-Harcourt et al. | Sep 2014 | B2 |
8916742 | Smith | Dec 2014 | B2 |
8986270 | Johannison et al. | Mar 2015 | B2 |
9033942 | Vess | May 2015 | B2 |
9061095 | Adie et al. | Jun 2015 | B2 |
9220822 | Hartwell | Dec 2015 | B2 |
9254353 | Locke et al. | Feb 2016 | B2 |
9265665 | Robinson et al. | Feb 2016 | B2 |
9579411 | Addison et al. | Feb 2017 | B2 |
20010000795 | Bolian, II et al. | May 2001 | A1 |
20010016985 | Insley et al. | Aug 2001 | A1 |
20010018308 | Quick et al. | Aug 2001 | A1 |
20010027302 | Glaug et al. | Oct 2001 | A1 |
20010027305 | Raidel et al. | Oct 2001 | A1 |
20010044610 | Kim et al. | Nov 2001 | A1 |
20010051178 | Blatchford et al. | Dec 2001 | A1 |
20010053904 | Abuto | Dec 2001 | A1 |
20020007167 | Dan et al. | Jan 2002 | A1 |
20020007169 | Graef et al. | Jan 2002 | A1 |
20020019602 | Geng | Feb 2002 | A1 |
20020019614 | Woon et al. | Feb 2002 | A1 |
20020026166 | Graef et al. | Feb 2002 | A1 |
20020034914 | De Leon et al. | Mar 2002 | A1 |
20020035354 | Mirle et al. | Mar 2002 | A1 |
20020062113 | Thomas et al. | May 2002 | A1 |
20020064639 | Rearick et al. | May 2002 | A1 |
20020087136 | Widlund | Jul 2002 | A1 |
20020090511 | Smith et al. | Jul 2002 | A1 |
20020110672 | Muratore-Pallatino et al. | Aug 2002 | A1 |
20020123728 | Graef et al. | Sep 2002 | A1 |
20020133132 | Copat et al. | Sep 2002 | A1 |
20020150678 | Cramer et al. | Oct 2002 | A1 |
20020165509 | Baer et al. | Nov 2002 | A1 |
20020176964 | Koslow | Nov 2002 | A1 |
20020177831 | Daley et al. | Nov 2002 | A1 |
20020180092 | Abba et al. | Dec 2002 | A1 |
20020183704 | Fields et al. | Dec 2002 | A1 |
20030009122 | Veras | Jan 2003 | A1 |
20030045707 | West et al. | Mar 2003 | A1 |
20030045825 | Etheredge, III | Mar 2003 | A1 |
20030050617 | Chen et al. | Mar 2003 | A1 |
20030069563 | Johnson | Apr 2003 | A1 |
20030070780 | Chen et al. | Apr 2003 | A1 |
20030073967 | Wahlstrom et al. | Apr 2003 | A1 |
20030088229 | Baker et al. | May 2003 | A1 |
20030088231 | Yoshimasa et al. | May 2003 | A1 |
20030093044 | Wahlstrom et al. | May 2003 | A1 |
20030097101 | Schmidt et al. | May 2003 | A1 |
20030097105 | Chen et al. | May 2003 | A1 |
20030097113 | Molee | May 2003 | A1 |
20030105442 | Johnston et al. | Jun 2003 | A1 |
20030114816 | Underhill et al. | Jun 2003 | A1 |
20030114818 | Benecke et al. | Jun 2003 | A1 |
20030114821 | Underhill et al. | Jun 2003 | A1 |
20030120249 | Wulz et al. | Jun 2003 | A1 |
20030121588 | Pargass et al. | Jul 2003 | A1 |
20030124311 | Cree et al. | Jul 2003 | A1 |
20030134559 | Delzer et al. | Jul 2003 | A1 |
20030135174 | Benecke et al. | Jul 2003 | A1 |
20030135177 | Baker | Jul 2003 | A1 |
20030150551 | Baker | Aug 2003 | A1 |
20030157857 | Cook et al. | Aug 2003 | A1 |
20030171729 | Kaun et al. | Sep 2003 | A1 |
20030180341 | Gooch et al. | Sep 2003 | A1 |
20030190854 | Stagray | Oct 2003 | A1 |
20030199800 | Levin | Oct 2003 | A1 |
20030208175 | Gross et al. | Nov 2003 | A1 |
20030212359 | Butler | Nov 2003 | A1 |
20030225383 | Glaug et al. | Dec 2003 | A1 |
20040019338 | Litvay et al. | Jan 2004 | A1 |
20040019339 | Ranganathan et al. | Jan 2004 | A1 |
20040019340 | McBride | Jan 2004 | A1 |
20040019342 | Nagasuna et al. | Jan 2004 | A1 |
20040024102 | Hayes | Feb 2004 | A1 |
20040024375 | Litvay | Feb 2004 | A1 |
20040033750 | Everett et al. | Feb 2004 | A1 |
20040049146 | Kolte et al. | Mar 2004 | A1 |
20040054343 | Barnett et al. | Mar 2004 | A1 |
20040054344 | Roettger et al. | Mar 2004 | A1 |
20040065420 | Graef et al. | Apr 2004 | A1 |
20040076662 | Riesinger | Apr 2004 | A1 |
20040078016 | Baker | Apr 2004 | A1 |
20040087927 | Suzuki | May 2004 | A1 |
20040111074 | Eliasson | Jun 2004 | A1 |
20040138602 | Rossen | Jul 2004 | A1 |
20040177935 | Hamed et al. | Sep 2004 | A1 |
20040181199 | Moberg-Alehammar et al. | Sep 2004 | A1 |
20040204696 | Chen | Oct 2004 | A1 |
20040230173 | Barge et al. | Nov 2004 | A1 |
20040230184 | Babusik et al. | Nov 2004 | A1 |
20040241214 | Kirkwood et al. | Dec 2004 | A1 |
20040243042 | Lipman | Dec 2004 | A1 |
20040243080 | Baer | Dec 2004 | A1 |
20040243081 | Suzuki et al. | Dec 2004 | A1 |
20040253894 | Fell et al. | Dec 2004 | A1 |
20040254552 | Mangold | Dec 2004 | A1 |
20050008825 | Casey et al. | Jan 2005 | A1 |
20050013992 | Azad et al. | Jan 2005 | A1 |
20050015036 | Lutri et al. | Jan 2005 | A1 |
20050049566 | Vukos et al. | Mar 2005 | A1 |
20050079361 | Hamed et al. | Apr 2005 | A1 |
20050096616 | Arora et al. | May 2005 | A1 |
20050112979 | Sawyer et al. | May 2005 | A1 |
20050119631 | Giloh et al. | Jun 2005 | A1 |
20050136773 | Yahiaoui et al. | Jun 2005 | A1 |
20050165371 | Giacometti | Jul 2005 | A1 |
20050215965 | Schmidt et al. | Sep 2005 | A1 |
20050215967 | Toro et al. | Sep 2005 | A1 |
20050222547 | Beruda et al. | Oct 2005 | A1 |
20050228353 | Thomas | Oct 2005 | A1 |
20050261649 | Cohen | Nov 2005 | A1 |
20050267429 | Cohen | Dec 2005 | A1 |
20060003604 | Angerpointner | Jan 2006 | A1 |
20060009744 | Erdman et al. | Jan 2006 | A1 |
20060020250 | Chester et al. | Jan 2006 | A1 |
20060058750 | Di Girolamo et al. | Mar 2006 | A1 |
20060069366 | Cole | Mar 2006 | A1 |
20060069367 | Waksmundzki et al. | Mar 2006 | A1 |
20060069375 | Waksmundzki et al. | Mar 2006 | A1 |
20060122548 | Abrams | Jun 2006 | A1 |
20060122572 | Suarez | Jun 2006 | A1 |
20060153904 | Smith et al. | Jul 2006 | A1 |
20060161122 | Erdman et al. | Jul 2006 | A1 |
20060178650 | Hakansson et al. | Aug 2006 | A1 |
20060184147 | Hamed | Aug 2006 | A1 |
20060206047 | Lampe et al. | Sep 2006 | A1 |
20060206073 | Crane et al. | Sep 2006 | A1 |
20060206074 | Bernal et al. | Sep 2006 | A1 |
20060241542 | Gudnason et al. | Oct 2006 | A1 |
20060282028 | Howard et al. | Dec 2006 | A1 |
20070003604 | Jones | Jan 2007 | A1 |
20070021697 | Ginther et al. | Jan 2007 | A1 |
20070073254 | Ponomarenko et al. | Mar 2007 | A1 |
20070078467 | Mullen | Apr 2007 | A1 |
20070100308 | Miyairi | May 2007 | A1 |
20070142804 | Bernard | Jun 2007 | A1 |
20070167096 | Scott | Jul 2007 | A1 |
20070167884 | Mangrum et al. | Jul 2007 | A1 |
20070224903 | Chakravarty et al. | Sep 2007 | A1 |
20070225663 | Watt et al. | Sep 2007 | A1 |
20070254550 | Hamed et al. | Nov 2007 | A1 |
20070270070 | Hamed | Nov 2007 | A1 |
20070282236 | LaGreca | Dec 2007 | A1 |
20080004581 | Babusik et al. | Jan 2008 | A1 |
20080015532 | Waksmundzki | Jan 2008 | A1 |
20080058691 | Sorensen | Mar 2008 | A1 |
20080082075 | Morrell-Schwartz | Apr 2008 | A1 |
20080090050 | Seyler et al. | Apr 2008 | A1 |
20080091152 | Asherman | Apr 2008 | A1 |
20080114317 | Seyler | May 2008 | A1 |
20080119586 | Byerly et al. | May 2008 | A1 |
20080147024 | Potts et al. | Jun 2008 | A1 |
20080167592 | Greer | Jul 2008 | A1 |
20080243100 | Wu et al. | Oct 2008 | A1 |
20080254103 | Harris et al. | Oct 2008 | A1 |
20080255533 | Wu et al. | Oct 2008 | A1 |
20080275409 | Kane et al. | Nov 2008 | A1 |
20080312621 | Hundorf et al. | Dec 2008 | A1 |
20080312622 | Hundorf et al. | Dec 2008 | A1 |
20090062760 | Wright et al. | Mar 2009 | A1 |
20090065014 | Nagata | Mar 2009 | A1 |
20090076472 | Goldwasser et al. | Mar 2009 | A1 |
20090112175 | Bissah et al. | Apr 2009 | A1 |
20090204087 | Herfert et al. | Aug 2009 | A1 |
20090216168 | Eckstein | Aug 2009 | A1 |
20090227935 | Zanella et al. | Sep 2009 | A1 |
20090227969 | Jaeb et al. | Sep 2009 | A1 |
20090240218 | Braga et al. | Sep 2009 | A1 |
20090281471 | Iwahashi et al. | Nov 2009 | A1 |
20090293887 | Wilkes et al. | Dec 2009 | A1 |
20090299251 | Buan | Dec 2009 | A1 |
20090299255 | Kazala, Jr. et al. | Dec 2009 | A1 |
20090299340 | Kazala, Jr. et al. | Dec 2009 | A1 |
20100010461 | Herfert et al. | Jan 2010 | A1 |
20100030171 | Canada et al. | Feb 2010 | A1 |
20100036334 | Heagle et al. | Feb 2010 | A1 |
20100036342 | Carlucci et al. | Feb 2010 | A1 |
20100048072 | Kauschke et al. | Feb 2010 | A1 |
20100055158 | Vitaris et al. | Mar 2010 | A1 |
20100069858 | Olson | Mar 2010 | A1 |
20100084074 | McClernon et al. | Apr 2010 | A1 |
20100087767 | McNeil | Apr 2010 | A1 |
20100106120 | Holm | Apr 2010 | A1 |
20100106121 | Holm | Apr 2010 | A1 |
20100121286 | Locke et al. | May 2010 | A1 |
20100121298 | Seyler et al. | May 2010 | A1 |
20100122417 | Vrzalik et al. | May 2010 | A1 |
20100125234 | Smith | May 2010 | A1 |
20100125258 | Coulthard et al. | May 2010 | A1 |
20100168695 | Robles et al. | Jul 2010 | A1 |
20100179463 | Greener et al. | Jul 2010 | A1 |
20100217177 | Cali et al. | Aug 2010 | A1 |
20100256545 | Aali et al. | Oct 2010 | A1 |
20100256584 | Litvay | Oct 2010 | A1 |
20100256586 | Bergstrom et al. | Oct 2010 | A1 |
20100262091 | Larsson | Oct 2010 | A1 |
20100305526 | Robinson et al. | Dec 2010 | A1 |
20100318047 | Ducker et al. | Dec 2010 | A1 |
20100318052 | Ha et al. | Dec 2010 | A1 |
20100324516 | Braga et al. | Dec 2010 | A1 |
20110004172 | Eckstein et al. | Jan 2011 | A1 |
20110052664 | Tennican et al. | Mar 2011 | A1 |
20110054422 | Locke et al. | Mar 2011 | A1 |
20110059329 | Dobrawa et al. | Mar 2011 | A1 |
20110060303 | Bissah et al. | Mar 2011 | A1 |
20110092927 | Wilkes et al. | Apr 2011 | A1 |
20110098621 | Fabo et al. | Apr 2011 | A1 |
20110106030 | Scholz | May 2011 | A1 |
20110112492 | Bharti et al. | May 2011 | A1 |
20110125119 | Weismantel et al. | May 2011 | A1 |
20110137222 | Masini | Jun 2011 | A1 |
20110152813 | Ellingson | Jun 2011 | A1 |
20110178375 | Forster | Jul 2011 | A1 |
20110183109 | Seyler et al. | Jul 2011 | A1 |
20110184364 | Biggs et al. | Jul 2011 | A1 |
20110184370 | Seyler et al. | Jul 2011 | A1 |
20110208145 | Zhang et al. | Aug 2011 | A1 |
20110213286 | Riesinger | Sep 2011 | A1 |
20110218509 | Dontas | Sep 2011 | A1 |
20110223413 | Herfert et al. | Sep 2011 | A1 |
20110224631 | Simmons et al. | Sep 2011 | A1 |
20110238026 | Zhang et al. | Sep 2011 | A1 |
20110245788 | Marquez Canada | Oct 2011 | A1 |
20110247636 | Pollack | Oct 2011 | A1 |
20110257572 | Locke et al. | Oct 2011 | A1 |
20110268932 | Catalan et al. | Nov 2011 | A1 |
20120004632 | Zhang et al. | Jan 2012 | A1 |
20120045639 | Whitmore et al. | Feb 2012 | A1 |
20120053547 | Schroeder et al. | Mar 2012 | A1 |
20120071848 | Zhang et al. | Mar 2012 | A1 |
20120095426 | Visscher et al. | Apr 2012 | A1 |
20120101465 | McGuire, Jr. | Apr 2012 | A1 |
20120123311 | Weidemann-Hendrickson et al. | May 2012 | A1 |
20120130332 | Cotton et al. | May 2012 | A1 |
20120136329 | Carney | May 2012 | A1 |
20120143158 | Yang et al. | Jun 2012 | A1 |
20120172778 | Rastegar et al. | Jul 2012 | A1 |
20120197229 | Buan et al. | Aug 2012 | A1 |
20120203145 | Nilsson | Aug 2012 | A1 |
20120220968 | Confalone et al. | Aug 2012 | A1 |
20120232502 | Lowing | Sep 2012 | A1 |
20120238932 | Atteia et al. | Sep 2012 | A1 |
20120283529 | Marchand et al. | Nov 2012 | A1 |
20120302440 | Theliander et al. | Nov 2012 | A1 |
20120308780 | Rottger et al. | Dec 2012 | A1 |
20120310186 | Moghe et al. | Dec 2012 | A1 |
20120310197 | Thomas | Dec 2012 | A1 |
20120330252 | Stokes et al. | Dec 2012 | A1 |
20120330253 | Robinson et al. | Dec 2012 | A1 |
20130012902 | Rovaniemi | Jan 2013 | A1 |
20130197460 | Shaw | Aug 2013 | A1 |
20140114268 | Auguste et al. | Apr 2014 | A1 |
20150159066 | Hartwell et al. | Jun 2015 | A1 |
20150174304 | Askem et al. | Jun 2015 | A1 |
20180125720 | Pigg | May 2018 | A1 |
20190110932 | Mumby et al. | Apr 2019 | A1 |
20190216651 | Vitaris et al. | Jul 2019 | A1 |
Number | Date | Country |
---|---|---|
101002707 | Jul 2007 | CN |
0053936 | Jun 1982 | EP |
0147119 | Jul 1985 | EP |
0541251 | May 1993 | EP |
0619105 | Oct 1994 | EP |
0748894 | Dec 1996 | EP |
0875224 | Nov 1998 | EP |
0941726 | Sep 1999 | EP |
1013290 | Jun 2000 | EP |
1048278 | Nov 2000 | EP |
1066809 | Jan 2001 | EP |
1312328 | May 2003 | EP |
1452156 | Sep 2004 | EP |
1 314 410 | Feb 2010 | EP |
2161011 | Mar 2010 | EP |
2366721 | Sep 2011 | EP |
2659915 | Oct 2015 | EP |
2272917 | Jun 1994 | GB |
2355228 | Apr 2001 | GB |
2435422 | Aug 2007 | GB |
2435423 | Aug 2007 | GB |
2489947 | Oct 2012 | GB |
2525494 | Oct 2015 | GB |
2001145655 | May 2001 | JP |
2007275185 | Oct 2007 | JP |
2008119497 | May 2008 | JP |
WO-9111161 | Aug 1991 | WO |
WO-9111162 | Aug 1991 | WO |
WO-9301778 | Feb 1993 | WO |
WO-9301781 | Feb 1993 | WO |
WO-9311726 | Jun 1993 | WO |
WO-9513042 | May 1995 | WO |
WO-9513779 | May 1995 | WO |
WO-9514451 | Jun 1995 | WO |
WO-9516424 | Jun 1995 | WO |
WO-9607783 | Mar 1996 | WO |
WO-9621410 | Jul 1996 | WO |
WO-9711658 | Apr 1997 | WO |
WO-9714384 | Apr 1997 | WO |
WO-9820916 | May 1998 | WO |
WO-9822279 | May 1998 | WO |
WO-9904830 | Feb 1999 | WO |
WO-9939671 | Aug 1999 | WO |
WO-9945876 | Sep 1999 | WO |
WO-9945878 | Sep 1999 | WO |
WO-9956687 | Nov 1999 | WO |
WO-0000016 | Jan 2000 | WO |
WO-0000127 | Jan 2000 | WO |
WO-0000129 | Jan 2000 | WO |
WO-0000130 | Jan 2000 | WO |
WO-0000131 | Jan 2000 | WO |
WO-0040190 | Jul 2000 | WO |
WO-0042957 | Jul 2000 | WO |
WO-0059438 | Oct 2000 | WO |
WO-0172251 | Oct 2001 | WO |
WO-0190465 | Nov 2001 | WO |
WO-0217840 | Mar 2002 | WO |
WO-0224132 | Mar 2002 | WO |
WO-0226180 | Apr 2002 | WO |
WO-0238096 | May 2002 | WO |
WO-02076379 | Oct 2002 | WO |
WO-03057307 | Jul 2003 | WO |
WO-03073971 | Sep 2003 | WO |
WO-2004043321 | May 2004 | WO |
WO-2004073566 | Sep 2004 | WO |
WO-2004098474 | Nov 2004 | WO |
WO-2006105305 | Oct 2006 | WO |
WO-2007035038 | Mar 2007 | WO |
WO-2007040606 | Apr 2007 | WO |
WO-2007077214 | Jul 2007 | WO |
WO-2007077216 | Jul 2007 | WO |
WO-2007082538 | Jul 2007 | WO |
WO-2007116347 | Oct 2007 | WO |
WO-2007134516 | Nov 2007 | WO |
WO-2008049277 | May 2008 | WO |
WO-2008131895 | Nov 2008 | WO |
WO-2009019227 | Feb 2009 | WO |
WO-2009019229 | Feb 2009 | WO |
WO-2009103031 | Aug 2009 | WO |
WO-2009152021 | Dec 2009 | WO |
WO-2010032951 | Mar 2010 | WO |
WO-2010072395 | Jul 2010 | WO |
WO-2010082872 | Jul 2010 | WO |
WO-2010089448 | Aug 2010 | WO |
WO-2010139926 | Dec 2010 | WO |
WO-2011019476 | Feb 2011 | WO |
WO-2011023275 | Mar 2011 | WO |
WO-2011023650 | Mar 2011 | WO |
WO 2011057240 | May 2011 | WO |
WO-2011058311 | May 2011 | WO |
WO-2011063818 | Jun 2011 | WO |
WO-2011113728 | Sep 2011 | WO |
WO-2011128651 | Oct 2011 | WO |
WO-2011152368 | Dec 2011 | WO |
WO-2012009370 | Jan 2012 | WO |
WO-2012035787 | Mar 2012 | WO |
WO-2012074512 | Jun 2012 | WO |
WO-2012146656 | Nov 2012 | WO |
WO-2012150235 | Nov 2012 | WO |
WO-2012168298 | Dec 2012 | WO |
WO-2013014317 | Jan 2013 | WO |
WO-2013029652 | Mar 2013 | WO |
WO-2013060732 | May 2013 | WO |
WO-2013175306 | Nov 2013 | WO |
WO-2014003957 | Jan 2014 | WO |
WO 2017174332 | Oct 2017 | WO |
WO 2018077872 | May 2018 | WO |
WO-2019020550 | Jan 2019 | WO |
9605526 | Feb 1997 | ZA |
Entry |
---|
Brief Communication—Letter from the Proprietor of the Patent dated Jun. 16, 2020, for the Opposition of European Patent No. EP2731564, 19 pages. |
International Preliminary Report on Patentability for Application No. PCT/EP2017/077154, dated May 9, 2019, 8 pages. |
International Preliminary Report on Patentability for Application No. PCT/GB2012/000587, dated Jan. 23, 2014, 12 pages. |
International Search Report and Written Opinion for Application No. PCT/GB2012/000587, dated Oct. 8, 2013, 17 pages. |
KCI Licensing Inc, “Prevena™ Incision Management System—Clinician Guide—Instructions for Use,” 390061 Rev D, Jan. 2010, 10 pages. |
KCI Licensing Inc, “Prevena™ Incision Management System—Clinician Guide—Instructions for Use,” 390153-WEB Rev B, Jan. 2010, 12 pages. |
KCI Licensing, “Prevena™ Incision Management System—Patient Guide”, 390064 Rev D, Jan. 2010, 4 pages. |
KCI Licensing, “Prevena™ Incision Management System—Patient Guide,” 390152-WEB C, Jan. 2011, 6 pages. |
KCI Licensing, Prevena™ Incision Management System, Jun. 22, 2010, in 2 pages. |
Notice of Opposition—Statement of Facts and Evidence for the European Patent No. 2731564, mailed Jan. 22, 2020, 12 pages. |
Smith & Nephew, Allevyn Gentle Border Multisite, Jun. 2011, 2 pages. |
Smith and Nephew Inc., “Allevyn Wound Dressings Pamphlet,” 2008, 2 pages. |
International Search Report and Written Opinion, re PCT Application No. PCT/EP2017/077154, dated Dec. 1, 2017. |
Number | Date | Country | |
---|---|---|---|
20190274889 A1 | Sep 2019 | US |